BioMap

About:

BioMap is a pioneer in life science AI Foundation Models

Website: http://www.biomap.com/

Twitter/X: BiomapI

Top Investors: BlueRun Ventures, Legend Capital, GGV Capital, Baidu, Hong Kong Investment Corporation Limited

Description:

Founded in 2020 by Robin Li and Wei Liu, BioMap is a disruptive life science AI company responsible for building xTrimo, the first and largest protein-centric large language model platform. Their technology allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. Supported by an international, cross-functional team of over 300 experts, BioMap is solving critical, protein-related drug development problems and charting a course to radically improve patients’ lives.